Pfizer's pill, called Paxlovid, is already authorized for use in people ages 12 and up.
Even though children are less likely than adults to be hospitalized or die from the virus, some of them do. Children in the U.S.
account for roughly 1 percent to 4 percent of those hospitalized from Covid and less than 1 percent of deaths, according to89 percent effectiveEven though that trial didn't include participants under age 18, the Food and Drug Administration authorized the pills for some at-risk children as young as 12 anyway.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Requiring masks in K-12 schools cut Covid-19 infections, study showsAs states are rolling back masking requirements for students, a new study shows masks helped cut Covid-19 infections in public K-12 schools that required them in the fall.
Read more »
COVID live updates: COVID testing center opens at Moscone Center in SFSF's Travel Association opened the facility to provide visitors, meeting attendees, and residents quick and easy access to affordable testing seven days a week.
Read more »
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
Most Side Effects From Pfizer, Moderna Covid Shots Are Mild And Short-Lived, Major Study FindsI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »